502. Early COVID-19 Treatment with SARS-CoV-2 Neutralizing Antibody Sotrovimab

BACKGROUND: COVID-19 disproportionately results in hospitalization and death in older patients and those with underlying comorbidities. Sotrovimab is a pan-sarbecovirus monoclonal antibody that binds a highly conserved epitope of the SARS-CoV-2 receptor binding domain and has an Fc modification that...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Anil K, Rojas, Yaneicy Gonzalez, Juarez, Erick, Casal, Manuel Crespo, Moya, Jaynier, Falci, Diego Rodrigues, Sarkis, Elias H, Solis, Joel, Zheng, Hanzhe, Scott, Nicola, Cathcart, Andrea L, Hebner, Christy, Sager, Jennifer, Mogalian, Erik, Austin, Daren, Peppercorn, Amanda, Alexander, Elizabeth L, Yeh, Wendy W, Free, Almena, Brinson, Cynthia, Aldinger, Melissa, Shapiro, Adrienne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644137/
http://dx.doi.org/10.1093/ofid/ofab466.701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644137/
http://dx.doi.org/10.1093/ofid/ofab466.701

Ejemplares similares